3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
5
Hematologic Neoplasms
5
Neoplasms
4
Prostatic Neoplasms
2
Multiple Myeloma
2
Lung Neoplasms
2
Hematopoietic and Lymphatic System Neoplasm
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Weight Cycling
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Tobacco Use Cessation
1
Substance-Related Disorders
1
Smoldering Multiple Myeloma
1
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Obesity-Related Malignant Neoplasm
1
Neoplasm Metastasis
1
Motor Activity
1
Mental Disorders
1
Insulin Resistance
1
Hematopoietic and Lymphoid System Neoplasm
1
Head and Neck Neoplasms
1
Head and Neck Carcinoma
1
Genital Neoplasms, Female
1
Interventions
venetoclax
188
Azacitidine
160
Cytarabine
127
fludarabine
96
Cyclophosphamide
74
Specimen Handling
68
fludarabine phosphate
56
Daunorubicin
53
Biopsy
49
Decitabine
47
Whole-Body Irradiation
42
Mycophenolic Acid
40
Idarubicin
40
Busulfan
37
Tacrolimus
35
Injections
35
Granulocyte Colony-Stimulating Factor
35
Melphalan
32
Stem Cell Transplantation
30
gilteritinib
25
Filgrastim
25
CPX-351
25
decitabine and cedazuridine drug combination
23
Peripheral Blood Stem Cell Transplantation
22
Etoposide
20
Mitoxantrone
19
Cladribine
19
ivosidenib
18
Thiotepa
17
Sirolimus
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Acute
×
Behavior Therapy
×
1 year
×
Clear all
No trials found.